Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender benefit in laparoscopic surgical performance using a 3D-display system: data from a randomized cross-over trial.
Busshoff J, Datta RR, Bruns T, Kleinert R, Morgenstern B, Pfister D, Chiapponi C, Fuchs HF, Thomas M, Gietzelt C, Hedergott A, Möller D, Hellmich M, Bruns CJ, Stippel DL, Wahba R. Busshoff J, et al. Among authors: moller d. Surg Endosc. 2022 Jun;36(6):4376-4385. doi: 10.1007/s00464-021-08785-4. Epub 2021 Nov 8. Surg Endosc. 2022. PMID: 34750707 Free PMC article. Clinical Trial.
3D vs. 4K Display System - Influence of "State-of-the-art"-Display Technique On Surgical Performance (IDOSP-Study) in minimally invasive surgery: protocol for a randomized cross-over trial.
Wahba R, Datta RR, Hedergott A, Bußhoff J, Bruns T, Kleinert R, Dieplinger G, Fuchs H, Gietzelt C, Möller D, Hellmich M, Bruns CJ, Stippel DL. Wahba R, et al. Among authors: moller d. Trials. 2019 May 28;20(1):299. doi: 10.1186/s13063-019-3330-7. Trials. 2019. PMID: 31138290 Free PMC article.
3D Versus 4K Display System - Influence of "State-of-the-art"-Display Technique on Surgical Performance (IDOSP-study) in Minimally Invasive Surgery: A Randomized Cross-over Trial.
Wahba R, Datta R, Bußhoff J, Bruns T, Hedergott A, Gietzelt C, Dieplinger G, Fuchs H, Morgenstern B, Möller D, Hellmich M, Bruns CJ, Stippel DL. Wahba R, et al. Among authors: moller d. Ann Surg. 2020 Nov;272(5):709-714. doi: 10.1097/SLA.0000000000004328. Ann Surg. 2020. PMID: 32833763 Free PMC article. Clinical Trial.
Correction to: 3D vs. 4 K Display System - Influence of "State-of-the-art"-Display Technique On Surgical Performance (IDOSP-Study) in minimally invasive surgery: protocol for a randomized cross-over trial.
Wahba R, Datta RR, Hedergott A, Bußhoff J, Bruns T, Kleinert R, Dieplinger G, Fuchs H, Gietzelt C, Möller D, Hellmich M, Bruns CJ, Stippel DL. Wahba R, et al. Among authors: moller d. Trials. 2020 Mar 12;21(1):257. doi: 10.1186/s13063-020-4173-y. Trials. 2020. PMID: 32164794 Free PMC article.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrøm SZ, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators. Butler J, et al. Among authors: moller dv. Lancet. 2024 Apr 27;403(10437):1635-1648. doi: 10.1016/S0140-6736(24)00469-0. Epub 2024 Apr 7. Lancet. 2024. PMID: 38599221 Clinical Trial.
Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study.
Olloni A, Brink C, Lorenzen EL, Jeppesen SS, Hofmann L, Kristiansen C, Knap MM, Møller DS, Nygård L, Persson GF, Thing RS, Sand HMB, Diederichsen A, Schytte T. Olloni A, et al. Among authors: moller ds. JTO Clin Res Rep. 2024 Mar 14;5(4):100663. doi: 10.1016/j.jtocrr.2024.100663. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38590728 Free PMC article.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ; STEP-HFpEF DM Trial Committees and Investigators. Kosiborod MN, et al. Among authors: moller dv. N Engl J Med. 2024 Apr 18;390(15):1394-1407. doi: 10.1056/NEJMoa2313917. Epub 2024 Apr 6. N Engl J Med. 2024. PMID: 38587233 Clinical Trial.
567 results